Exelixis Inc
NASDAQ:EXEL

Watchlist Manager
Exelixis Inc Logo
Exelixis Inc
NASDAQ:EXEL
Watchlist
Price: 39.6 USD 1.83% Market Closed
Market Cap: 10.9B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

EXEL Price Targets Summary
Exelixis Inc

Wall Street analysts forecast EXEL stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EXEL is 38.71 USD with a low forecast of 29.29 USD and a high forecast of 47.25 USD.

EXEL Lowest Forecast
Wall Street Target
29.29 USD
26% Downside
EXEL Average Forecast
Wall Street Target
38.71 USD
2% Downside
EXEL Highest Forecast
Wall Street Target
47.25 USD
19% Upside
Lowest
Price Target
29.29 USD
26% Downside
Average
Price Target
38.71 USD
2% Downside
Highest
Price Target
47.25 USD
19% Upside
Exelixis Inc Competitors:
Price Targets
4587
PeptiDream Inc
81% Upside
IMMX
Immix Biopharma Inc
241% Upside
TRDA
Entrada Therapeutics Inc
169% Upside
SLNO
Soleno Therapeutics Inc
35% Upside
4587
PeptiDream Inc
81% Upside
IMMX
Immix Biopharma Inc
241% Upside
TRDA
Entrada Therapeutics Inc
169% Upside
SLNO
Soleno Therapeutics Inc
35% Upside
CDNA
CareDx Inc
111% Upside
M
MAB
Mabion SA
24% Downside
IMNM
Immunome Inc
173% Upside
XGN
Exagen Inc
14% Upside

Revenue
Forecast

Revenue Estimate
Exelixis Inc

For the last 8 years the compound annual growth rate for Exelixis Inc's revenue is 35%. The projected CAGR for the next 3 years is 10%.

35%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Exelixis Inc

The compound annual growth rate of Exelixis Inc's operating income for the next 3 years is 19%.

N/A
Past Growth
19%
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Exelixis Inc

The compound annual growth rate of Exelixis Inc's net income for the next 3 years is 20%.

N/A
Past Growth
20%
Estimated Growth
Estimates Accuracy
23%
Average Beat
What are analyst estimates?

See Also

Summary
EXEL intrinsic value, competitors valuation, and company profile.
DCF Valuation
EXEL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EXEL stock valuation using valuation multiples.
Wall Street Estimates
EXEL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EXEL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is EXEL's stock price target?
Price Target
38.71 USD

According to Wall Street analysts, the average 1-year price target for EXEL is 38.71 USD with a low forecast of 29.29 USD and a high forecast of 47.25 USD.

What is Exelixis Inc's Revenue forecast?
Projected CAGR
10%

For the last 8 years the compound annual growth rate for Exelixis Inc's revenue is 35%. The projected CAGR for the next 3 years is 10%.

What is Exelixis Inc's Operating Income forecast?
Projected CAGR
19%

The compound annual growth rate of Exelixis Inc's operating income for the next 3 years is 19%.

What is Exelixis Inc's Net Income forecast?
Projected CAGR
20%

The compound annual growth rate of Exelixis Inc's net income for the next 3 years is 20%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 252,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.